During the past decade, Southern Alberta Clinic conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southern Alberta Clinic" #1 sponsor was "Gilead Sciences" with 2 trials, followed by "Glaxo Wellcome" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Kirby Institute" with 2 trials sponsored and "Argos Therapeutics" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southern Alberta Clinic" #1 collaborator was "CIHR Canadian HIV Trials Network" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Epidemiology Coordinating and Research Centre, Canada" with 1 trials as a collaborator, "Glaxo Wellcome" with 1 trials as a collaborator and "Ontario HIV Treatment Network" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Southern Alberta Clinic" are "HIV Infections" (10 trials), "HIV" (4 trials), "Acquired Immunodeficiency Syndrome" (1 trials), "Cytomegalovirus Infections" (1 trials) and "Cytomegalovirus Retinitis" (1 trials). Many other conditions were trialed in "Southern Alberta Clinic" in a lesser frequency.

Most popular intervention types in "Southern Alberta Clinic" are "Drug" (11 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (3 trials), "Efavirenz" (2 trials), "Lamivudine" (2 trials), "AGS-004" (1 trials) and "ATV" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southern Alberta Clinic" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Southern Alberta Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Southern Alberta Clinic, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Southern Alberta Clinic, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".

Southern Alberta Clinic has several departments that took part in Clinical trials: "Stollery Children's Hospital Emergency Department" - 4 trials, "Movement Disorder Program, Foothills Medical Center, Alberta Health Services" - 3 trials, "Foothills Hospital Intensive Care Unit" - 3 trials, "University of Calgary Liver Unit" - 2 trials, "West Edmonton Diabetes Center" - 2 trials, "Foothills Medical Centre; Centre Dept of Medical Clinical Neuroscience" - 2 trials, "Foothills Medical Centre Sleep Centre" - 2 trials, "Heart Health Institute, Rockyview General Hospital" - 2 trials, "University of Alberta Hospital, Pharmacy Services" - 2 trials, "University of Alberta Hospital Emergency Department" - 2 trials